<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>298(3)</volume><submitter>Protze J</submitter><funding>DFG</funding><pubmed_abstract>Evolution of clear cell renal cell carcinoma is guided by dysregulation of hypoxia-inducible transcription factor (HIF) pathways following loss of the von Hippel-Lindau tumor suppressor protein. Renal cell carcinoma (RCC)-associated polymorphisms influence HIF-DNA interactions at enhancers of important oncogenes thereby modulating the risk of developing renal cancer. A strong signal of genome-wide association with RCC was determined for the single nucleotide polymorphism (SNP) rs4903064, located on chr14q.24.2 within an intron of DPF3, encoding for Double PHD Fingers 3, a member of chromatin remodeling complexes; however, it is unclear how the risk allele operates in renal cells. In this study, we used tissue specimens and primary renal cells from a large cohort of RCC patients to examine </pubmed_abstract><journal>The Journal of biological chemistry</journal><pagination>101699</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8897700</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression.</pubmed_title><pmcid>PMC8897700</pmcid><pubmed_authors>Kraus A</pubmed_authors><pubmed_authors>Schiffer M</pubmed_authors><pubmed_authors>Wiesener M</pubmed_authors><pubmed_authors>Protze J</pubmed_authors><pubmed_authors>Naas S</pubmed_authors><pubmed_authors>Kruger R</pubmed_authors><pubmed_authors>Hartmann A</pubmed_authors><pubmed_authors>Schodel J</pubmed_authors><pubmed_authors>Grampp S</pubmed_authors><pubmed_authors>Stohr C</pubmed_authors><pubmed_authors>Wullich B</pubmed_authors></additional><is_claimable>false</is_claimable><name>The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression.</name><description>Evolution of clear cell renal cell carcinoma is guided by dysregulation of hypoxia-inducible transcription factor (HIF) pathways following loss of the von Hippel-Lindau tumor suppressor protein. Renal cell carcinoma (RCC)-associated polymorphisms influence HIF-DNA interactions at enhancers of important oncogenes thereby modulating the risk of developing renal cancer. A strong signal of genome-wide association with RCC was determined for the single nucleotide polymorphism (SNP) rs4903064, located on chr14q.24.2 within an intron of DPF3, encoding for Double PHD Fingers 3, a member of chromatin remodeling complexes; however, it is unclear how the risk allele operates in renal cells. In this study, we used tissue specimens and primary renal cells from a large cohort of RCC patients to examine </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-31T08:57:29.678Z</modification><creation>2024-11-10T06:08:56.464Z</creation></dates><accession>S-EPMC8897700</accession><cross_references><pubmed>35148991</pubmed><doi>10.1016/j.jbc.2022.101699</doi></cross_references></HashMap>